Description

2-(n-(Diphenylmethyl)Amino)Propanoic Acid-4-((2-Methyl-3-Pyridinyl)Cyanomethyl)Piperazine is a sophisticated, high-value pharmaceutical intermediate with a complex molecular architecture designed for targeted synthesis. This compound is critical for research and development chemists working on novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring specific receptor binding profiles. Its primary value lies in enabling the synthesis of advanced drug candidates, making it essential for pharmaceutical companies, contract research organizations (CROs), and academic research institutions focused on medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the multi-step synthesis of novel drug candidates, particularly in central nervous system (CNS) and anti-inflammatory therapeutic areas.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize the potency and selectivity of lead compounds.
• Process Chemistry Development: Employed in scaling up synthetic routes from laboratory to pilot plant scale, focusing on yield optimization and impurity profile control.
• API Synthesis: A critical precursor in the manufacturing of complex active pharmaceutical ingredients that incorporate diphenylmethyl and piperazine motifs.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of clinical trial materials and commercial APIs.
• Biochemical Tool Compound: Potential use in biochemical assays to study specific enzyme or receptor interactions due to its designed structural features.

Basic Information

Product Name	2-(n-(Diphenylmethyl)Amino)Propanoic Acid-4-((2-Methyl-3-Pyridinyl)Cyanomethyl)Piperazine
CAS No.	150812-44-5
Molecular Formula	C28H30N4O2
Molecular Weight	454.57 g/mol
Synonyms	4-[(2-Methyl-3-pyridinyl)cyanomethyl]-1-[2-(diphenylmethylamino)propionyl]piperazine; 1-[2-(Benzhydrylamino)propionyl]-4-[(2-methyl-3-pyridinyl)cyanomethyl]piperazine; 2-(Diphenylmethylamino)propanoic acid 4-[(2-methyl-3-pyridinyl)cyanomethyl]piperazide; 150812-44-5; UNII-9Q2K7E6F2I; 9Q2K7E6F2I; A piperazine derivative (CAS 150812-44-5)
EINECS	Contact for details

Quality Control

Our production of 2-(n-(Diphenylmethyl)Amino)Propanoic Acid-4-((2-Methyl-3-Pyridinyl)Cyanomethyl)Piperazine adheres to stringent quality management systems, ensuring batch-to-batch consistency for critical R&D and scale-up work. Each lot undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry. We provide detailed Certificates of Analysis (COA) with each shipment, documenting all critical quality attributes. Our quality commitment aligns with cGMP principles where applicable, supporting its use in pharmaceutical development pipelines.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.